Skip to Main Content

Advertisement

Skip Nav Destination

Strategic Pricing of New Pharmaceuticals

The Review of Economics and Statistics (1998) 80 (1): 108–118.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
  • Alice M. Ellyson
  • Anirban Basu
Health Economics (2021) 30 (5): 1070.
  • James M. Plečnik
  • Leo L. Yang
  • Joseph H. Zhang
Accounting & Finance (2021)
  • Frank R. Lichtenberg
Health Economics (2021) 30 (8): 1910.
  • Mark V. Pauly
  • William S. Comanor
  • H.E. Frech
  • Joseph R. Martinez
Value in Health (2021) 24 (10): 1476.
  • Kathleen Iacocca
  • Beth Vallen
Journal of Public Policy & Marketing (2021) 40 (4): 538.
  • Fanor Balderrama
  • Lisa J. Schwartz
  • Christopher J. Longo
Health Care Analysis (2020) 28 (2): 121.
  • Sabrina Terrizzi
  • Chad Meyerhoefer
Contemporary Economic Policy (2020) 38 (1): 94.
  • Son Le
  • Neel U. Sukhatme
International Review of Law and Economics (2020) 64: 105934.
  • Simona Gamba
  • Paolo Pertile
  • Sabine Vogler
Health Economics (2020) 29 (S1): 47.
  • Kozo Ueda
  • Kota Watanabe
  • Tsutomu Watanabe
American Economic Journal: Macroeconomics (2019) 11 (2): 310.
  • Alexander Roediger
  • Tim Wilsdon
  • Artes Haderi
  • Kathy Pendleton
  • Boris Azais
Health Policy (2019) 123 (7): 652.
  • Carolin Mauch
  • Jens Robert Schöndube
European Accounting Review (2019) 28 (1): 151.
  • Michael L. Lanthier
  • Kirk W. Kerr
  • Kathleen L. Miller
Clinical Pharmacology & Therapeutics (2019) 106 (5): 1125.
  • Maria Angelica Borges dos Santos
  • Leticia Lucia dos Santos Dias
  • Cláudia Du Bocage Santos Pinto
  • Rondineli Mendes da Silva
  • Claudia Garcia Serpa Osorio-de-Castro
Journal of Pharmaceutical Policy and Practice (2019) 12 (1)
  • Ameet Sarpatwari
  • Jonathan DiBello
  • Marie Zakarian
  • Mehdi Najafzadeh
  • Aaron S. Kesselheim
  • Joel Lexchin
PLOS Medicine (2019) 16 (7): e1002872.
  • Margaret K. Kyle
Review of Industrial Organization (2018) 53 (1): 211.
  • William S. Comanor
  • Stuart O. Schweitzer
  • Jon M. Riddle
  • Frederic Schoenberg
Review of Industrial Organization (2018) 52 (4): 589.
  • Weiwei Chen
  • Mark Messonnier
  • Fangjun Zhou
Health Economics (2018) 27 (2): 252.
  • Jörg Mahlich
  • Isao Kamae
  • Rosarin Sruamsiri
Expert Review of Pharmacoeconomics & Outcomes Research (2018) 18 (3): 339.
  • Mingyue Zhao
  • Jing Wu
Expert Review of Pharmacoeconomics & Outcomes Research (2017) 17 (3): 311.
  • David B. Ridley
  • Su Zhang
International Journal of Industrial Organization (2017) 50: 186.
  • G. Caleb Alexander
  • Jeromie Ballreich
  • Mariana P. Socal
  • Taruja Karmarkar
  • Antonio Trujillo
  • Jeremy Greene
  • Joshua Sharfstein
  • Gerard Anderson
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2017) 37 (11): 1469.
  • Daniel S. Hosken
  • Luke M. Olson
  • Loren K. Smith
Economic Inquiry (2016) 54 (1): 342.
  • Geoffrey F. Joyce
  • Neeraj Sood
Journal of Policy Analysis and Management (2016) 35 (4): 970.
  • JA DiMasi
  • R Chakravarthy
Clinical Pharmacology & Therapeutics (2016) 100 (6): 754.
  • Yu-Hung Chen
  • Baojun Jiang
SSRN Electronic Journal (2016)
  • David H. Howard
  • Peter B. Bach
  • Ernst R. Berndt
  • Rena M. Conti
Journal of Economic Perspectives (2015) 29 (1): 139.
  • Sara Parker-Lue
  • Michael Santoro
  • Greg Koski
Annual Review of Pharmacology and Toxicology (2015) 55 (1): 191.
  • Ali Shajarizadeh
  • Aidan Hollis
Health Economics (2015) 24 (8): 966.
  • Kathleen Iacocca
  • James Sawhill
  • Yao Zhao
International Journal of Pharmaceutical and Healthcare Marketing (2015) 9 (1): 3.
  • Richard G. Frank
  • Raymond S. Hartman
International Journal of the Economics of Business (2015) 22 (2): 301.
  • Michael T. Mueller
  • Alexander Frenzel
The European Journal of Health Economics (2015) 16 (1): 73.
  • Jing Wu
  • Judy Xu
  • Gordon Liu
  • Jiuhong Wu
PharmacoEconomics (2014) 32 (3): 293.
  • William S. Comanor
  • Stuart O. Schweitzer
ECONOMIA E POLITICA INDUSTRIALE (2014) (1): 55.
  • Moshe Levy
  • Adi Rizansky Nir
  • Toshiaki Abe
PLoS ONE (2014) 9 (11): e113894.
  • Jaume Puig-Junoy
  • Beatriz González López-Valcárcel
Health Policy (2014) 116 (2-3): 170.
  • Panagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research (2014) 14 (5): 627.
  • Sandy Campart
  • Etienne Pfister
Economics of Innovation and New Technology (2014) 23 (3): 215.
  • Alexandre de Corniere
  • Greg Taylor
SSRN Electronic Journal (2014)
  • Stephane Régnier
Health Care Management Science (2013) 16 (4): 300.
  • Maria-Angeles de Frutos
  • Carmine Ornaghi
  • Georges Siotis
Journal of Health Economics (2013) 32 (1): 268.
  • Antonio Cabrales
  • Sergi Jiménez-Martín
Health Economics (2013) 22 (11): 1377.
  • Saradindu Bhaduri
  • Thomas Brenner
The European Journal of Health Economics (2013) 14 (5): 761.
Close Modal

or Create an Account

Close Modal
Close Modal